BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29344645)

  • 1. Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice.
    Ye Q; Li G; Liu S; Guan Y; Li Y; Li J; Jia H; Li X; Li Q; Huang R; Wang H; Zhang Y
    Int J Mol Med; 2018 Apr; 41(4):2177-2184. PubMed ID: 29344645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
    Cao Y; Jansen ID; Sprangers S; Stap J; Leenen PJ; Everts V; de Vries TJ
    J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis
    Wang L; Fang B; Fujiwara T; Krager K; Gorantla A; Li C; Feng JQ; Jennings ML; Zhou J; Aykin-Burns N; Zhao H
    J Biol Chem; 2018 Jun; 293(24):9248-9264. PubMed ID: 29724825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
    Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
    J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
    Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
    Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.
    Reinke DC; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2016 Nov; 164():353-360. PubMed ID: 26639637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption.
    Khor EC; Abel T; Tickner J; Chim SM; Wang C; Cheng T; Ng B; Ng PY; Teguh DA; Kenny J; Yang X; Chen H; Nakayama KI; Nakayama K; Pavlos N; Zheng MH; Xu J
    PLoS One; 2013; 8(8):e70815. PubMed ID: 23951014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RARγ is a negative regulator of osteoclastogenesis.
    Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
    J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Runx1-mediated regulation of osteoclast differentiation and function.
    Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
    Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss.
    Wu Y; Tworkoski K; Michaud M; Madri JA
    J Immunol; 2009 Mar; 182(5):2672-9. PubMed ID: 19234161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis.
    Gorissen B; de Bruin A; Miranda-Bedate A; Korthagen N; Wolschrijn C; de Vries TJ; van Weeren R; Tryfonidou MA
    J Cell Physiol; 2018 Jan; 234(1):414-426. PubMed ID: 29932209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
    Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
    Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
    Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
    J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
    Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
    Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.